These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 9400368)

  • 1. Crystal structure of phenylmethanesulfonyl fluoride-treated human chymase at 1.9 A.
    McGrath ME; Mirzadegan T; Schmidt BF
    Biochemistry; 1997 Nov; 36(47):14318-24. PubMed ID: 9400368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The 2.2 A crystal structure of human chymase in complex with succinyl-Ala-Ala-Pro-Phe-chloromethylketone: structural explanation for its dipeptidyl carboxypeptidase specificity.
    Pereira PJ; Wang ZM; Rubin H; Huber R; Bode W; Schechter NM; Strobl S
    J Mol Biol; 1999 Feb; 286(1):163-73. PubMed ID: 9931257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure of human pro-chymase: a model for the activating transition of granule-associated proteases.
    Reiling KK; Krucinski J; Miercke LJ; Raymond WW; Caughey GH; Stroud RM
    Biochemistry; 2003 Mar; 42(9):2616-24. PubMed ID: 12614156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crystal structure of an elastase-specific inhibitor elafin complexed with porcine pancreatic elastase determined at 1.9 A resolution.
    Tsunemi M; Matsuura Y; Sakakibara S; Katsube Y
    Biochemistry; 1996 Sep; 35(36):11570-6. PubMed ID: 8794736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Substituted 3-(phenylsulfonyl)-1-phenylimidazolidine-2,4-dione derivatives as novel nonpeptide inhibitors of human heart chymase.
    Niwata S; Fukami H; Sumida M; Ito A; Kakutani S; Saitoh M; Suzuki K; Imoto M; Shibata H; Imajo S; Kiso Y; Tanaka T; Nakazato H; Ishihara T; Takai S; Yamamoto D; Shiota N; Miyazaki M; Okunishi H; Kinoshita A; Urata H; Arakawa K
    J Med Chem; 1997 Jul; 40(14):2156-63. PubMed ID: 9216834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A structural model for the prostate disease marker, human prostate-specific antigen.
    Villoutreix BO; Getzoff ED; Griffin JH
    Protein Sci; 1994 Nov; 3(11):2033-44. PubMed ID: 7535613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thermodynamic criterion for the conformation of P1 residues of substrates and of inhibitors in complexes with serine proteinases.
    Qasim MA; Lu SM; Ding J; Bateman KS; James MN; Anderson S; Song J; Markley JL; Ganz PJ; Saunders CW; Laskowski M
    Biochemistry; 1999 Jun; 38(22):7142-50. PubMed ID: 10353824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Substituted 3-phenylsulfonylquinazoline-2,4-dione derivatives as novel nonpeptide inhibitors of human heart chymase.
    Fukami H; Imajo S; Ito A; Kakutani S; Shibata H; Sumida M; Tanaka T; Niwata S; Saitoh M; Kiso Y; Miyazaki M; Okunishi H; Urata H; Arakawa K
    Drug Des Discov; 2000; 17(1):69-84. PubMed ID: 10928450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Three-dimensional molecular modeling explains why catalytic function for angiotensin-I is different between human and rat chymases.
    Yamamoto D; Shiota N; Takai S; Ishida T; Okunishi H; Miyazaki M
    Biochem Biophys Res Commun; 1998 Jan; 242(1):158-63. PubMed ID: 9439628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 1.70 A X-ray structure of human apo kallikrein 1: structural changes upon peptide inhibitor/substrate binding.
    Laxmikanthan G; Blaber SI; Bernett MJ; Scarisbrick IA; Juliano MA; Blaber M
    Proteins; 2005 Mar; 58(4):802-14. PubMed ID: 15651049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design of noncovalent trypsin inhibitor based on the X-ray crystal structure of the complex.
    Nakamura M; Tomoo K; Ishida T; Taguchi H; Tsuda Y; Okada Y; Okunomiya A; Wanaka K; Okamoto S
    Biochem Biophys Res Commun; 1995 Aug; 213(2):583-7. PubMed ID: 7646515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel substrate-binding pocket interaction restricts the specificity of the human NK cell-specific serine protease, Met-ase-1.
    Smyth MJ; O'Connor MD; Trapani JA; Kershaw MH; Brinkworth RI
    J Immunol; 1996 Jun; 156(11):4174-81. PubMed ID: 8666785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The extended substrate specificity of the human mast cell chymase reveals a serine protease with well-defined substrate recognition profile.
    Andersson MK; Enoksson M; Gallwitz M; Hellman L
    Int Immunol; 2009 Jan; 21(1):95-104. PubMed ID: 19073880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Albumin is a substrate of human chymase. Prediction by combinatorial peptide screening and development of a selective inhibitor based on the albumin cleavage site.
    Raymond WW; Ruggles SW; Craik CS; Caughey GH
    J Biol Chem; 2003 Sep; 278(36):34517-24. PubMed ID: 12815038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The extended cleavage specificity of the rodent beta-chymases rMCP-1 and mMCP-4 reveal major functional similarities to the human mast cell chymase.
    Andersson MK; Karlson U; Hellman L
    Mol Immunol; 2008 Feb; 45(3):766-75. PubMed ID: 17681377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitory mechanism of daphnodorins for human chymase.
    Sakaguchi M; Yamamoto D; Takai S; Jin D; Taniguchi M; Baba K; Miyazaki M
    Biochem Biophys Res Commun; 2001 May; 283(4):831-6. PubMed ID: 11350059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crystal structure of recombinant human tissue kallikrein at 2.0 A resolution.
    Katz BA; Liu B; Barnes M; Springman EB
    Protein Sci; 1998 Apr; 7(4):875-85. PubMed ID: 9568894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The crystal structure of PR3, a neutrophil serine proteinase antigen of Wegener's granulomatosis antibodies.
    Fujinaga M; Chernaia MM; Halenbeck R; Koths K; James MN
    J Mol Biol; 1996 Aug; 261(2):267-78. PubMed ID: 8757293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel serine protease inhibition motif involving a multi-centered short hydrogen bonding network at the active site.
    Katz BA; Elrod K; Luong C; Rice MJ; Mackman RL; Sprengeler PA; Spencer J; Hataye J; Janc J; Link J; Litvak J; Rai R; Rice K; Sideris S; Verner E; Young W
    J Mol Biol; 2001 Apr; 307(5):1451-86. PubMed ID: 11292354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crystal structure of the caspase activator human granzyme B, a proteinase highly specific for an Asp-P1 residue.
    Estébanez-Perpiña E; Fuentes-Prior P; Belorgey D; Braun M; Kiefersauer R; Maskos K; Huber R; Rubin H; Bode W
    Biol Chem; 2000 Dec; 381(12):1203-14. PubMed ID: 11209755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.